Amyotrophic lateral sclerosis--a new role for old drugs.
Brown
Robert H
RH
Massachusetts General Hospital, Boston, USA.
D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002443:Ceftriaxone / Q000494:pharmacology* / Q000627:therapeutic use; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical; D027342:Excitatory Amino Acid Transporter 2 / Q000096:biosynthesis / Q000187:drug effects* / Q000235:genetics; D018698:Glutamic Acid / Q000378:metabolism; D051379:Mice; D018696:Neuroprotective Agents / Q000494:pharmacology* / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D027342:Excitatory Amino Acid Transporter 2; D018696:Neuroprotective Agents; D018698:Glutamic Acid; D002443:Ceftriaxone